Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 28 (RPS29P28) is a processed pseudogene found in the human genome that is derived from the functional ribosomal protein S29 gene (RPS29)[4][9][11]. Pseudogenes like RPS29P28 resemble their parent protein-coding genes in sequence but contain disabling mutations (such as frameshifts or premature stop codons) that prevent them from producing functional proteins[11]. RPS29P28 thus does not encode a functional ribosomal protein, is not transcribed into an active protein or RNA product with biological activity, and is not considered a therapeutic target, receptor, enzyme, transporter, or any functional molecule in disease or pharmacology[4][11]. The existence of multiple ribosomal protein pseudogenes is common in the human genome, resulting primarily from retrotransposition events[11]. According to authoritative gene databases, there is no evidence that RPS29P28 is expressed or has clinical, pharmacological, or biomarker relevance[4][9][11]. In contrast, the functional parent gene (RPS29) is critical for ribosome function and mutations in RPS29 are associated with Diamond-Blackfan anemia and other disorders[6][7][10], but pseudogenes derived from RPS29, such as RPS29P28, do not share these associations. Therefore, if your intent is to identify a functional or druggable protein/receptor, RPS29P28 should not be considered a valid target[4][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 28 (RPS29P28).